SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HELIX BIOPHARMA (HBP:TSE)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: marcos who wrote (95)8/20/1997 8:01:00 PM
From: trustmanic   of 193
 
This Summer is bad for biotech. No one really know about the Dow. As long as the interest rate is low,people get nothing from saving account or GIC, they have to buy mutual fund and eventually the money will go into the stock market. I thought about this question a million times about cash, although you could buy back stock later and cheaper, but if you put money into saving, you end up paying tax for the little interest they gave you + your wife want to spend it on something for future garage sales or a vacation trip end up with arguement. Anyway its almost a one way solution for most of the people --buy mutual fund. Biotech stock depended on individual merit. IMT got a Mexican deal and the clinical result will come out in Sept.I think the stock will turn around in mid Sept. good or bad. As for NVN, I would say the end of the year, but they have a few deals to work on,one after another, all good deal takes time.HBP is really for long term, they don't have a scientific break through product, so we have to wait for their products sales and a better balance sheet. I missed NVO.Summer will be over soon. Enjoy it.

George
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext